文献速递消化道肿瘤与早癌

胃癌中三级淋巴结构相关B细胞增强CXCL13+CD103+CD8+组织驻留记忆T细胞对PD-1阻断的应答

Tertiary lymphoid structure-associated B cells enhance CXCL13+CD103+CD8+Trm cell response to PD-1 blockade in gastric cancer.
PubMed 文献 · Gastroenterology · 2023-10-27

该研究探讨胃癌中三级淋巴结构(TLS)内B细胞与CXCL13+CD103+CD8+组织驻留记忆T(Trm)细胞的相互作用及其在免疫治疗中的作用。免疫染色显示TLS和CXCL13+CD103+CD8+Trm细胞的存在与胃癌患者抗PD-1治疗更优应答相关;活化的B细胞通过LTα/TNFR2轴和mTOR信号促进CD103+CD8+Trm细胞糖酵解,增强其CXCL13和颗粒酶B分泌。

要点

  • 胃癌组织中TLS和CXCL13+CD103+CD8+Trm细胞的存在与抗PD-1治疗更优应答相关
  • 活化的B细胞增强CD103+CD8+Trm细胞分泌CXCL13和颗粒酶B
  • B细胞通过LTα/TNFR2轴促进CD103+CD8+Trm细胞糖酵解,mTOR信号通路起关键作用

核心结论

  • 本研究进一步揭示了TLS相关B细胞与CXCL13+CD103+CD8+Trm细胞之间的细胞通讯在抗肿瘤免疫中的关键作用,为利用CXCL13+CD103+CD8+Trm细胞内的LTα/TNFR2轴推进胃癌免疫治疗策略提供了重要见解。

研究设计与样本

  • 对胃癌患者肿瘤切片进行TLS和CXCL13+CD103+CD8+Trm细胞的免疫染色和HE染色。
  • 在体外和体内确定B细胞与CXCL13+CD103+CD8+Trm细胞之间的通讯机制。
  • 通过抗PD-1治疗评估CXCL13+CD103+CD8+Trm细胞抑制肿瘤生长的作用。

主要发现

  • 肿瘤组织中TLS和CXCL13+CD103+CD8+Trm细胞的存在有利于胃癌患者对抗PD-1治疗获得更优应答。
  • 活化的B细胞增强CD103+CD8+Trm细胞分泌CXCL13和颗粒酶B。
  • B细胞通过LTα/TNFR2轴促进CD103+CD8+Trm细胞糖酵解,mTOR信号通路在此过程中对CD103+CD8+Trm细胞糖酵解起关键作用。
  • TLS和CXCL13+CD103+CD8+Trm细胞的存在以TNFR2依赖的方式与抗PD-1治疗的强应答相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Although the presence of tertiary lymphoid structures (TLS) correlates with positive responses to immunotherapy in many solid malignancies, the mechanism by which TLS enhances anti-tumor immunity is not well understood. The present study aimed to investigate the underlying cross-talk circuits between B cells and tissue-resident memory T (Trm) cells within the TLS and to understand their role in the context of immunotherapy. METHODS: Immunostaining and hematoxylin and eosin staining of TLS and CXCL13+CD103+CD8+Trm cells were performed on tumor sections from patients with gastric cancer (GC). The mechanism of communication between B cells and CXCL13+CD103+CD8+Trm cells was determined both in vitro and in vivo. The effect of CXCL13+CD103+CD8+Trm cells in suppressing tumor growth was evaluated through anti-PD-1 therapy. RESULTS: The presence of TLS and CXCL13+CD103+CD8+Trm cells in tumor tissues favored a superior response to anti-PD-1 therapy in GC patients. Additionally, our research identified that activated B cells enhanced CXCL13 and granzyme B secretion by CD103+CD8+Trm cells. Mechanistically, B cells facilitated the glycolysis of CD103+CD8+Trm cells through the Lymphotoxin Alpha (LTα)/Tumor necrosis factor receptor 2 (TNFR2) axis, and the mTOR signaling pathway played a critical role in CD103+CD8+Trm cells glycolysis during this process. Moreover, the presence of TLS and CXCL13+CD103+CD8+Trm cells correlated with potent responsiveness to anti-PD-1 therapy in a TNFR2 dependent manner. CONCLUSIONS: This study further reveals a crucial role for cellular communication between TLS-associated B cell and CXCL13+CD103+CD8+Trm cells in anti-tumor immunity, providing valuable insights into the potential utilization of the LTα/TNFR2 axis within CXCL13+CD103+CD8+Trm cells for advancing immunotherapy strategies in GC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hu C, You W, Kong D, et al. Tertiary lymphoid structure-associated B cells enhance CXCL13+CD103+CD8+Trm cell response to PD-1 blockade in gastric cancer. Gastroenterology. 2023. PMID: 39491204. doi:10.1053/j.gastro.2023.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。